Okla. Stat. tit. 63, § 63-1-270.2: Human embryo – Stem cell research – Reporting system

A. For the purposes of the Advancement in Stem Cell Cures and

Therapies Act, "human embryo" means a living organism of the species

Homo sapiens at the earliest stage of development, including the

single-cell stage, that is not located in the body of a woman.

B. Research on human tissue regeneration and human diseases

using adult stem cells and stem cells obtained from umbilical cord

blood and amniotic fluid may be conducted in this state, provided

that the research is performed:

1. Safely and ethically;

2. Only on embryonic stem cell lines created prior to August 1,

2001, and in accordance with federal law as it existed on November

1, 2007; and

3. Without the use of a human embryo, including a human embryo

produced using cloning technology.

C. When research is performed in accordance with the

Advancement in Stem Cell Cures and Therapies Act, a person or

governmental body shall not:

1. Restrict public funds designated for the stem cell research;

or

2. Obstruct or provide disincentives for the stem cell

research.

D. The State Department of Health shall establish a reporting

system that collects information regarding all activities carried

out in accordance with this section.

E. The Department shall submit a report with all information

collected pursuant to subsection D of this section to the Governor,

the Speaker of the Oklahoma House of Representatives, and the

President Pro Tempore of the Oklahoma State Senate no later than

December 31 of each year.

F. Provided that there is no stem cell research to report that

year, the Department does not need to file a report.